|
|
Volumn 100, Issue 3, 2006, Pages 263-271
|
|
Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19
a
a
a
a
a
a
a
|
|
Author keywords
Analyses; Breast cancer; DPPE; Quality of life; Statistical methods; Tesmilifene
|
|
Indexed keywords
ANTHRACYCLINE;
ANTIEMETIC AGENT;
DOXORUBICIN;
SEDATIVE AGENT;
TESMILIFENE;
ADULT;
ADVANCED CANCER;
ALOPECIA;
ANALYTIC METHOD;
ANOREXIA;
ARTICLE;
ATAXIA;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PAIN;
CLINICAL ASSESSMENT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DIZZINESS;
DRUG INDUCED HEADACHE;
EXTRAPYRAMIDAL SYMPTOM;
FATIGUE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HALLUCINATION;
HEART FAILURE;
HUMAN;
INFECTION;
INJECTION SITE REACTION;
INTERMETHOD COMPARISON;
MAJOR CLINICAL STUDY;
METASTASIS;
MONOTHERAPY;
NAUSEA;
NEUROLOGIC DISEASE;
PAIN ASSESSMENT;
PATIENT COMPLIANCE;
PREMEDICATION;
PREVALENCE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL SIGNIFICANCE;
STATISTICS;
STOMATITIS;
VERTIGO;
VOMITING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CROSS-SECTIONAL STUDIES;
DOXORUBICIN;
FATIGUE;
FEMALE;
HEALTH STATUS;
HUMANS;
MIDDLE AGED;
NAUSEA;
NEOPLASM METASTASIS;
NEUROTOXICITY SYNDROMES;
PATIENT COMPLIANCE;
PHENYL ETHERS;
QUALITY OF LIFE;
QUESTIONNAIRES;
TREATMENT OUTCOME;
VOMITING;
|
|
EID: 33750735689
PISSN: 01676806
EISSN: None
Source Type: Journal
DOI: 10.1007/s10549-006-9257-1 Document Type: Article |
|
Times cited : (32)
|
|
References (10)
|
